2023 International Congress Archives - Page 82 of 186

Machine learning classifies Parkinson’s Disease and Progressive Supranuclear Palsy on saccade, pupil, and blink measures during a naturalistic free-viewing task

D. Brien, H. Riek, R. Yep, J. Huang, B. Coe, B. White, M. Habibi, D. Grimes, M. Jog, A. Lang, C. Marras, M. Masellis, P. Mclaughlin, A. Peltsch, A. Roberts, B. Tan, D. Beaton, W. Lou, E. Finger, A. Frank, D. Tang-Wai, C. Tartaglia, S. Black, R. Swartz, W. Oertel, D. Munoz (Kingston, Canada)
Machine learning diagnosis of parkinsonian syndromes: network approach with two different sites

M. Perovnik, T. Rus, A. Vo, N. Nguyen, P. Tomše, J. Jamšek, C. Tang, M. Trošt, D. Eidelberg (Ljubljana, Slovenia)
Machine Learning Model for Prediction of acute orthostatic hypotension after levodopa administration

Z. Liu, SN. Lin, ZL. Chen, Y. Ling, T. Feng (Beijing, China)
Machine Learning Prediction of Gait Dysfunction from DTI Multi-Spectral Diffusion Weighted Imaging ROIs

C. Raimondo, I. Ailes, I. Shelley, K. Shivok, M. Syed, M. Alizadeh (Philadelphia, USA)
Machine Learning Prediction of Motor Score Reduction following DBS Surgery in PD

C. Raimondo, C. Wu, M. Alizadeh (Philadelphia, USA)
Machine learning reveals candidate genes from Parkinson’s disease associated loci

E. Yu, R. Lariviere, R. Thomas, L. Liu, K. Senkevich, E. Fon, Z. Gan-Or (Montreal, Canada)
Machine learning selects common fMRI features of cognitive impairment in Parkinson’s disease from cross-institution datasets

CY. Chien, TY. Lin, TL. Lee, CCK. Lin (Tainan, Taiwan)
Make-up for Parkinson’s: a randomized control trial

M. Darabseh, A. Aburub (Amman, Jordan)
Making Parkinson’s care complete and global: an international survey of the “vitals” dashboard of Parkinson’s disease

M. Qamar, C. Falup-Pecurariu, L. Batzu, A. Podlewska, S. Rota, N. Titova, V. Metta, I. Murasan, D. Ziemele, R. van Coller, J. Carr, G. Chung-Faye, L. Ungureanu, K. Ray Chaudhuri (London, United Kingdom)
Making the invisible visible: A qualitative interview study on the impact of young onset Parkinson’s disease on (ex-)partners

W. Kapelle, A. Geerlings, I. Mutsaers, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)
Management of constipation in Parkinson’s patients presenting with acute sigmoid volvulus to Royal Berkshire Hospital,Reading, UK

M. Khwaja, S. Alam, E. Castaneda-Caicedo, A. Chatterjee (Reading, United Kingdom)
Management of Sigmoid Volvulus in Parkinson’s patients presenting to Royal Berkshire Hospital, Reading ,UK.

M. Khwaja, S. Alam, A. Chatterjee, E. Castaneda-Cicedo (Reading, United Kingdom)
Manifestations of aging and Parkinson’s Disease in low-frequency fluctuations of postural sway velocity

M. Latka, K. Kozlowska, A. Latka, M. Glaubic-Latka, S. Budrewicz, M. Koszewicz, T. Sebzda, BJ. West (Wroclaw, Poland)
Marked reduction of energy supply due to levodopa treatment in patients with Parkinson’s disease and healthy controls

J. Prasuhn, T. Schiefen, T. Grüber, J. Hekel, J. Uter, J. Steinhardt, B. Wilms, N. Brüggemann (Lübeck, Germany)
May CSF biomarkers have a role in degenerative parkinsonian syndromes workup?

C. Bernardes, JM. Alves, I. Cunha, D. Carneiro, J. Lemos, F. Moreira, MJ. Leitão, I. Baldeiras, I. Santana, A. Morgadinho (Coimbra, Portugal)
MDS-UPDRS III Off Severity Level changes as a marker of DBS response

S. Castillo-Torres, I. Cruz, M. Rossi, M. Wilken, D. Cerquetti, M. Merello (Buenos Aires, Argentina)
MDS-UPDRS Part 3 cannot be summed with other parts of the MDS-UPDRS: a clinimetric evaluation

C. Goetz, D. Choi, Y. Guo, G. Stebbins, T. Mestre, S. Luo (Chicago, USA)
Measures of trancranial magnetic evoked potentials for prediction of response to ventriculoparitoneal shunt In normal pressure hydrocephalus

T. Davidy, S. Anis, A. Sominski, J. Zauberman, T. Fay-Karmon, O. Lesman-Segev, S. Hassin-Baer (Ramat Gan, Israel)
Measuring the heterogeneity of disease progression in Parkinson’s disease with multimodal clinical milestones over 10 years in the DeNoPa cohort

S. Weber, M. Dakna, A. Bednorz, M. Bartl, E. Lang, T. Wicke, M. Starke, J. Ebentheuer, F. Sixel-Döring, M. Muntean, S. Schade, C. Trenkwalder, B. Mollenhauer (Goettingen, Germany)
Meige Syndrome Following COVID Infection

E. Girouard, A. Levy (Montréal, Canada)
Melatonin for huntington disease (HD) gene carriers with HD-related sleep disturbance – a pilot study

J. Patino, S. Zadegan, N. Rocha, N. Karagas, W. Tanigaki, B. Duncan, E. Furr Stimming (Houston, USA)
Membrane-associated properties and ER stress alterations in LRRK2 I1371V patient iPSC derived neurons increase susceptibility to oxidative stress.

S. Jagtap, I. Datta (Bengaluru, India)
MER length as a predictor of motor and non-motor outcomes of STN DBS in Parkinson’s disease

K. Pillai, S. Joshua, A. Nair, D. Panikar, M. Chacko, A. Thalakkattu, A. Avarachan, H. Prakash, A. Kishore (Kochi, India)
Mesencephalic neuroglial cyst can produce clinical manifestations and a metabolic [18F] FDG PET pattern mimicking a Progressive Supranuclear Palsy Syndrome

C. Espinoza-Vinces, V. Betech-Antar, A. Atorrasagasti, S. Solís-Barquero, C. Arrondo, G. Montoya, G. Martí-Andrés, MR. García-Eulate, J. Arbizu, MR. Luquin (Pamplona, Spain)
Metabolic connectivity assessed by dynamic FDG-fPET acquisition in Parkinson’s disease: a multimodal fPET and fMRI study

M. Ruppert-Junck, V. Heinecke, K. Steidel, M. Beckersjürgen, D. Librizzi, M. Luster, H. Müller, F. Verburg, L. Timmermann, C. Eggers, D. Pedrosa (Marburg, Germany)
Metabolic modulation of mitochondrial DNA release in cellular models of Parkin-associated Parkinson’s disease

G. Agyeah, P. Antony, K. Wasner, A. Rakovic, S. Pereira, A. Grünewald (Esch-Sur-Alzette, Luxembourg)
Metoclopramide-induced acute dystonic reaction caused by CYP2D6 *4/*4 and CYP2D6 *10/*10 genotypes

I. šarac, H. šarac, F. Borovečki, N. Božina, I. Ivek, L. Bagarić Krakan, Z. Krešić (Zagreb, Croatia)
Microbiota and Gastrointestinal Manifestations of Parkinson’s Disease with Arabic Translation of Gastrointestinal Dysfunction Scale

Y. Salah, N. Dawood, M. Salama, A. Shalash (cairo, Egypt)
Microelectrode recording with subthalamic nuclei deep brain stimulation encompass neuro-electro physiological beta oscillations footmarks in Parkinson`s cardinal motor symptoms sub-types

L. Neerati, G. Rama Raju, R. Venkateshwara (Hyderabad, India)
Microstructural abnormalities of the dentato-rubro thalamo-cortical tract in tremor dominant PD and ET plus syndrome: A DTI, NODDI and free water-based analysis

S. Prasad, A. Rajan, R. Bharath, P. Pal, J. Saini (Bengaluru, India)
Minimum clinically important difference (MCID) on the Unified Wilson Disease Rating Scale (UWDRS) Part III: results from the Phase 3 FoCus Trial

T. Litwin, A. Czlonkowska, P. Hedera, J. Bronstein, M. Lorincz, M. Møller, G. Wegmann, G. Carron, A. Messali, A. Poujois (Warsaw, Poland)
miRNAs from blood serum as an early diagnostic biomarker for Parkinson’s disease: A study in an animal model

MD. Ahmad, PSD. Dholaniya (Hyderabad, India)
Mitochondrial DNA copy number is associated with the severity of motor symptoms and dementia in Parkinson’s disease

S. Jo, JH. Oh, S. Lee, J. Lee, CO. Sung, SJ. Chung (Seoul, Republic of Korea)
Mobile and electronic health-supported physical activity in Parkinson’s disease: A scoping review

M. Bopp, J. Krell-Roesch, Y. Geda, S. Aslam, A. Woll (Karlsruhe, Germany)
Mobile Brain / Body Imaging in early Parkinson’s Disease: the Twin Brain project

M. Ajcevic, A. Buoite Stella, A. Miladinovic, M. Peskar, M. Kalc, T. Lombardo, M. Deodato, M. Catalan, U. Marusic, P. Manganotti (Trieste, Italy)
Modeling Parkinson’s disease progression accounting for the effect of symptomatic treatments in the Parkinson’s Progression Markers Initiative study

B. Ribba, T. Simuni, K. Marek, A. Siderowf, L. Chahine, C. Diack, A. Monnet, B. Ricci, T. Nikolcheva, G. Pagano (Basel, Switzerland)
Modifying clinical and electrophysiological parameters through Transcranial pulsed current stimulation (tPCS) in Huntington disease

M. Tuesta Bernaola, J. Ganguly, A. Parra Peña, M. Jog (London, Canada)
Modulation of a subthalamic nucleus related network associated with motor response following Deep Brain Stimulation

P. Unadkat, S. Peng, Y. Ma, V. Dhawan, C. Tang, A. Vo, S. Caminiti, D. Perani, D. Eidelberg (Manhasset, USA)
Modulation of autophagy and neuroinflammation by Niclosamide in MPTP Induced- Parkinson’s disease model

SHI. Kartik (Lucknow, India)
Modulation of pallidal activity by circadian rhythms: a new variable to be accounted for closed-loop DBS?

T. de Araujo, J. Cagle, F. Sarmento, K. Johnson, L. Almeida, C. de Hemptinne (Gainesville, USA)
modulation of sodium potassium ATPase activity by norepinepherine and serotonin to find an effective cure of parkinson’s disease by introducing the novel concept of insilico drug repurposing

S. Sinha (Prayagraj, India)
Modulatory effect of posture on prepulse inhibition in Parkinson’s disease and atypical Parkinsonism

M. Ciocca, Z. Hadi, S. Hosli, B. Seemungal, Y. Tai (London, United Kingdom)
Monoamine loss and depression in Parkinson’s disease: a PET study

BL. Xu, XL. Liu, SY. Liu, O. Barret, G. Tamagnan, H. Qiao, TB. Song, J. Lu, P. Chan (Beijing, China)
Monocular Ocular Bobbling with Holmes Tremor Due to Ruptured Cavernoma

S. Virameteekul, P. Panyakaew,, R. Bhidayasiri (Bangkok, Thailand)
Monogenic Dystonia and Deep Brain Stimulation: Single Center Experience

V. Racki, M. Hero, E. Papic, G. Rozmaric, M. Raguz, B. Petek, B. Peterlin, D. Chudy, V. Vuletic (Rijeka, Croatia)
monogenic parkinson´s disease in a chilean cohort

P. Saffie-Awad, D. Texeira, A. Schumacher-Schuh, T. Leal, M. Inca-Martinez, I. Mata, P. Chana-Cuevas (Santiago, Chile)
monogenic parkinsonism in latin america: systematic review and meta-analysis

P. Saffie-Awad, D. Texeira, P. Chana-Cuevas, A. Schumacher-Schuh (Santiago, Chile)
Montelukast as disease modifying treatment for Parkinson’s disease: a pilot study.

J. Wallin, P. Svenningsson (Stockholm, Sweden)
Morphometric assessment of age-associated neuronal changes in the human locus coeruleus

A. Bhattacharya, A. Mahadevan, R. Manjithaya, T. Yasha, P. Alladi (Bengaluru, India)
Mosaic divergent repeat interruptions in X-linked dystonia-parkinsonism: stability over generations and time

J. Laß, T. Lüth, K. Schlüter, RL. Rosales, RD. Jamora, G. Saranza, CCE. Diesta, S. Schaake, B. Laabs, N. Brüggemann, I. König, C. Klein, A. Westenberger, J. Trinh (Lübeck, Germany)
motor and non-motor correlates of hyposmia detected by the italian olfactory identification test (ioit) in an italian cohort of parkinson’s disease patients

A. Mechelli, N. Tambasco, M. Filidei, C. Maremmani, M. Pierini, P. Nigro, S. Simoni, L. Parnetti (Catanzaro, Italy)
Motor complications in Parkinson’s disease

S. Gandhi, T. Zerenner, A. Nodehi, M. Lawton, K. Grosset, V. Marshall, F. Al-Hajraf, Y. Ben-Shlomo, M. Hu, D. Grosset (Glasgow, United Kingdom)
Motor control of finger individuation and strength in patients with Parkinson’s disease and Spinocerebellar Ataxia type 12

S. Majumdar, A. Bayen, S. Choudhury, P. Basu, M. Baker, S. Baker, H. Kumar (Kolkata, India)
Motor evaluation of Parkinson disease and Vascular parkinsonism using the TUG encephalog application

L. Franken, J. Reiner, M. Mermelstein, D. Biederko, R. Djaldettti (Petah Tikva, Israel)
Motor function in Parkinson´s disease during 16h treatment with intravenously (DIZ101), subcutaneously (DIZ102), or intestinally (LCIG) infused levodopa

F. Bergquist, M. Ehrnebo, D. Nyholm, A. Johansson, F. Lundin, P. Odin, P. Svenningsson, N. Dizdar, E. Eriksson (Gothenburg, Sweden)
Motor imagery ability in patients with functional dystonia

A. Tomic, I. Petrovic, M. Jecmenica Lukic, V. Markovic, N. Kresojevic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)
Motor phenotype and disease burden among Parkinson’s disease patients of Addis Ababa, Ethiopia.

B. Getahun, H. Demissie, H. Nuri, S. Gugssa (Dire Dawa, Ethiopia)
Motor subtype stability and cognitive profiles in early Parkinson’s disease

N. Chia, S. Ng, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan (Singapore, Singapore)
Movement disorders (MD) after stroke in childhood

D. Munoz, M. Troncoso, F. Balut, V. Naranjo, M. Hidalgo, I. Ruiz (Santiago, Chile)
Movement Disorders (MD) Specialist Nurse pilot project in Australia’s Northern Territory (NT): One year of experience.

Y. Hernandez Gomez (Darwin, Australia)
Movement disorders at the National Institute of Neurology and Neurosurgery (INNN, Mexico City): most common diagnoses during 2022.

D P. Romero Teran, A J. Hernández Medrano, D R. Aguila Godinez, A A. Herrera Ruiz, E C. Santiago Cruz, M. Medrano Delgado, M A. Ruiz Mafud, A Y. Regalado Mustafá, M F. Medina Perez, G I. Cerda Hernández, M. Rodriguez Violante, A. Cervantes Arriaga, G. Hernandez Armesto, A. Abundes Corona, A. Dominguez Garcia, K. Talavera Lagunas (CDMX, Mexico)
Movement disorders in children with neurometabolic and neurodegenerative disorders: A single-center prospective study

A. Saini, S. Khanna, N. Sankhyan (Chandigarh, India)
Movement disorders in children with progressive myoclonic epilepsies

M. Ben Hafsa, H. Benrhouma, M. Jamoussi, T. Ben Younes, Z. Miladi, A. Zioudi, H. Klaa, I. Kraoua, I. Ben Youssef-Turki (Tunis, Tunisia)
Movement disorders in osmotic demyelination syndrome: A case series from a tertiary care centre

A. Panjwani, A. Kumar, A. Ranjan (Patna, India)
Movement disorders in the setting of dengue infection in a rural medical teaching hospital in Gujarat, India

D. Desai, S. Desai (Anand, India)
Movement disorders spectrum in CTNNB1-related neurodevelopmental disorders

G. Garone, M. Grasso, L. Travaglini, MC. Digilio, A. Capuano, F. Nicita, G. Della Bella, D. Diodato, L. Chioma, A. Mandarino, L. Sinibaldi (Rome, Italy)
Movement-related modulation of beta/high frequency oscillations and low-beta pallido-cortical coherence in Parkinson’s disease.

J. Aman, L. Johnson, J. Wang, D. Escobar Sanabria, M. Hill, S. Alberico, K. O'Neill, R. Patriat, N. Harel, S. Cooper, D. Darrow, R. Mcgovern Iii, M. Park, J. Vitek (Minneapolis, USA)
Moving beyond trial and error: a strategy for anatomically informed contact selection in subthalamic deep brain stimulation for Parkinson’s disease.

GA. Brandt, V. Stopic, C. Hennen, JN. Strelow, JN. Petry-Schmelzer, JC. Baldermann, MT. Barbe, V. Visser-Vandevalle, TA. Dembek (Cologne, Germany)
MR-guided focused ultrasound pallidothalamic tractotomy in non-tremor dominant (akinetic-rigid) Parkinson’s disease treatment

R. Galimova, G. Akhmadeeva, D. Nabiullina, F. Kashapov, O. Kachemaeva, YU. Sidorova, D. Teregulova, N. Mukhamadeeva, D. Krekotin, I. Buzaev, SH. Safin, S. Illarioshkin (Ufa, Russian Federation)
MR-morphological changes in PD patients with heterozygous GBA mutation

J. Reimer, K. Faust, GH. Schneider, AA. Kühn, P. Krause (Berlin, Germany)
MRgFUS thalamotomy in dystonic and essential tremor: a prospective study with one year follow up

N. Golfrè Andreasi, A. Braccia, F. Ghielmetti, LM. Romito, R. Cilia, AE. Elia, G. Devigili, G. Messina, V. Levi, S. Rinaldo, M. Corradi, G. Barbiera, F. Paio, M. Stanziano, S. Prioni, P. Amami, M. Fusarpoli, SHM. Piacentini, MG. Bruzzone, M. Grisoli, EFM. Ciceri, R. Eleopra (Milano, Italy)
MRI morphometry and regional hypometabolism in the clinical predominance-types of Progressive Supranuclear Palsy

H. Chovatiya, K. Pillai, R. Kamble, S. Santhamma, P. Rajeswari, M. Chacko, A. Kishore (Kochi, India)
Multi-stakeholder focus group study to develop recommendations of ways to improve treatment burden and capacity in Parkinson’s disease

QY. Tan, S. Fraser, H. Roberts, K. Ibrahim (Southampton, United Kingdom)
Multicenter, randomized, placebo-controlled, double-blind, parallel-group proof-of-concept study of lixisenatide in patients with early Parkinson’s disease (PD): the LIXIPARK trial (NCT03439943)

WG. Meissner, P. Remy, C. Giordana, D. Maltete, P. Damier, JL. Houeto, C. Geny, L. Hopes, F. Durif, G. Defer, C. Tranchant, JC. Corvol, N. Carriere, JP. Azulay, S. Drapier, P. Krystkowiak, C. Thalamas, A. Benard, O. Rascol, N. Ns-Park/fcrin (Bordeaux, France)
Multimodal imaging analysis of autosomal recessive Parkinson’s disease.

B. Soydas-Turan, G. Yalcin-Cakmakli, E. Yetim, B. Volkan-Salanci, E. Lay-Ergun, K. Karli-Oguz, B. Elibol (Ankara, Turkey)
Multimodal neuroimaging of Parkinson’s disease with diffusion tensor imaging (DTI) and dopamine transporter (DAT) positron emission tomography

P. Honhar, S. Tinaz, M. Dias, R. Comley, S. Finnema, R. Carson, D. Scheinost, D. Matuskey (New Haven, USA)
Multimodal neuroimaging to probe brain networks in Cervical Dystonia.

SR. Bostan, R. King, C. Fearon, M. Hutchinson, R. Reilly (Dublin, Ireland)
Multiple methods to improve recruitment, enrollment, and retention of study participants for validation of the Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)

M. Tosin, D. Hessl, J. O'Keefe, D. Hall (Chicago, USA)
Multiple N-of-1 trials to investigate hypoxia-based treatment in Parkinson’s disease: safety and short-term effects

J. Janssen Daalen, M. Meinders, F. Giardina, S. Mathur, P. Ainslie, D. Thijssen, B. Bloem (Nijmegen, Netherlands)
Muscle functions on the movement timings and inhibition in Parkinson’s disease.

H. Singh, K S. Anand (Mysore, India)
Musical Perception in Parkinson’s Disease, a Pilot Study

K. Vourou (Athens, Greece)
Mutation screening of PCDHGB1 variants in a large dystonia cohort

J. Lin, C. Li, Q. Jiang, R. Ou, Q. Wei, Y. Hou, L. Zhang, K. Liu, Y. Xiao, T. Yang, S. Wang, D. Pang, Y. Yu, Y. Cui, W. Song, B. Zhao, J. Yang, X. Chen, R. Huang, Y. Wu, H. Shang (Chengdu, China)
Myocardial sympathetic denervation biomarkers for early detection of prodromal DLB

M. Park, J. An (Daegu, Republic of Korea)
Myoclonus Phenomenology and its Response to Antiepileptic drugs in Patients with Sub acute Sclerosing Pan encephalitis

S. Pandey, K. Db, R. Garg, H. Malhotra, A. Jain, S. Kumar (LUCKNOW, India)
Myotonic Dystrophy type 1 presenting as postural tremor

MJ. Lima, P. Ferreira, S. Moreira, M. Calejo (Senhora da Hora, Portugal)